Cargando…
Need for a safe vaccine against respiratory syncytial virus infection
Human respiratory syncytial virus (HRSV) is a major cause of severe respiratory tract illnesses in infants and young children worldwide. Despite its importance as a respiratory pathogen, there is currently no licensed vaccine for HRSV. Following failure of the initial trial of formalin-inactivated v...
Autores principales: | Kim, Joo-Young, Chang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454572/ https://www.ncbi.nlm.nih.gov/pubmed/23049587 http://dx.doi.org/10.3345/kjp.2012.55.9.309 |
Ejemplares similares
-
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
por: Kim, Joo Young, et al.
Publicado: (2016) -
Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011) -
Universal vaccine against respiratory syncytial virus A and B subtypes
por: Lee, Jeong-Yoon, et al.
Publicado: (2017) -
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
por: Jorquera, Patricia A., et al.
Publicado: (2016) -
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
por: Lee, Hyo-Jeong, et al.
Publicado: (2017)